Home
Conditions
Cardiotoxicity

Clinical trial condition

Cardiotoxicity

Explore clinical trials studying Cardiotoxicity. Study availability and eligibility vary by location and protocol.

165 public trials 46 recruiting studies

Refine in advanced search Browse all conditions

Cardiotoxicity trial results

Not yet recruiting

Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

NCT03969693

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +19 more
Locations: Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Enrolling by invitation

Novel On-body Evaluation of Cardiac Health for Oncology

NCT07158450

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +7 more
Locations: Colorado Heart and Vascular Golden, Colorado, United States

Clearwater Cardiovascular Consultants Clearwater, Florida, United States

Midwest Cardiovascular Institute Naperville, Illinois, United States

Cardiovascular Institute of the South Houma, Louisiana, United States

View Trial Details

Enrolling by invitation

Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors

NCT06211413

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Cardiotoxicity, +25 more
Locations: Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Enrolling by invitation

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

NCT06332131

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
Locations: Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Enrolling by invitation

CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma

NCT06605833

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +19 more
Locations: The Royal Marsden NHS Foundation Trust London, United Kingdom

View Trial Details

Active, not recruiting

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

NCT04928261

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada

View Trial Details

Active, not recruiting

Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines

NCT05271162

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +6 more
Locations: Institute of Hematology and Transfusion Medicine Warsaw, Poland

National Institute of Oncology Warsaw, Poland

View Trial Details

Active, not recruiting

Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer

NCT05096338

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +17 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial

NCT07442578

Conditions: Anthracycline-induced Cardiotoxicity, Cardiotoxicity, Cardiovascular Diseases, +8 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, not recruiting

Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.

NCT06277388

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations: Hui Liu Guangzhou, Guangdong, China

View Trial Details

Cardiotoxicity

Cardiotoxicity trial results

Related conditions